Two patients with different blood diseases who were treated with CRISPR in the summer are showing significant improvements, according to new data released Tuesday.
HHS on Monday announced the rate of improper Medicare fee-for-service payments in fiscal year (FY) 2019 was at the lowest point since FY 2010.
FDA on Friday granted Pentax approval to market a duodenoscope with a sterile, disposable elevator—an innovation that reduces the number of parts that need to be cleaned, potentially lowering the odds of transmitting dangerous superbugs.